Figure 1 from Pertuzumab: Optimizing HER2 Blockade | Semantic Scholar
Dual HER2 blockade with trastuzumab and pertuzumab in HER2-amplified... | Download Scientific Diagram
Proposed Mechanism of Action | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
HER2-targeted therapies — a role beyond breast cancer | Nature Reviews Clinical Oncology
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
Pertuzumab is a fully humanized monoclonal antibody based on the human... | Download Scientific Diagram
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer | Journal for ImmunoTherapy of Cancer
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes - ScienceDirect
Pertuzumab in human epidermal growth-factor receptor 2-positive breast | IJWH
Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram
References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Pertuzumab: new hope for patients with HER2-positive breast cancer - ScienceDirect
Figure 1 | Recent Developments in HER2-Directed Therapy in Breast Cancer | SpringerLink
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism | Breast Cancer Research | Full Text
Pertuzumab in HER2-positive early breast cancer: current use and perspectives | Future Oncology
Proposed Mechanism of Action | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab - Annals of Oncology
Precision medicine and personalized breast cancer: combination pertuzu | PGPM
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity | Bentham Science
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer
Mechanisms and Actions of HER2-Targeting Agents in Breast Cancer (Transcript)
